PROgastrine COlon DEpistage

ECS-Progastrin

Status: Terminated

Conditions: Healthy Person; Colon Cancer Screening

Treatments: Diagnostic Test: progastrin

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT03775473

PROCODE

Details and patient eligibility

About

Dosage of progastrin in asymptomatic person participating in colon cancer screening

Full description

For anyone who will participate in colon screening at the Princess Grace Hospital of Monaco and who has signed the informed consent document. A blood test will be performed in addition to the screening test to assess the rate of progastrin.

Enrollment: 260 patients

Sex: All

Ages: 50 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• participant in colon cancer screening
• signing informed consent

Exclusion criteria

• any major medical, psychiatric or addictive illness that would affect the informed consent process
• The consent of a representative is not allowed in this study

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

260 participants in 1 patient group

progastrin

Other group

Description:

anyone who will participate in colon screening at the Princess Grace Hospital in Monaco and who has signed the informed consent document

Treatment:

Diagnostic Test: progastrin